Basic Materials / Specialty ChemicalsShanghai
$80.35
+1.15 (+1.45%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 35% · confianza 11%
FCF escenarios
weak_data · normalized FCF $-531.5M · quality 25.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
24/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$6.2B
P/E
182.6x
↑EV/EBITDA
13.2x
↑ROE
8.3%
↑Gross Margin
17.0%
↓Debt/Equity
10.62
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+14.6%
FCF CAGR
—
FCF margin
-9.8%
FCF / Net income
-15.10x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.83B · net income $31.3M · FCF $-473.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.83B | $4.83B | $1.27B | $2.67B | $3.21B |
| Net Income | $31.3M | $31.3M | $-366.9M | $-7.5M | $-32.4M |
| EBITDA | $737.4M | $737.4M | $-164.9M | $147.6M | $47.3M |
| EPS | 0.41 | 0.41 | -4.76 | -0.10 | -0.44 |
| Gross Margin | 17.0% | 17.0% | -4.9% | 5.3% | 5.8% |
| Operating Margin | 10.6% | 10.6% | -19.7% | 1.2% | 0.0% |
| Net Margin | 0.6% | 0.6% | -28.8% | -0.3% | -1.0% |
| Balance Sheet | |||||
| Debt/Equity | 10.62 | 10.62 | 5.65 | 1.72 | 1.39 |
| Current Ratio | 0.82 | 0.82 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-473.5M | $-473.5M | $-1.76B | $-531.5M | $-599.9M |
| Returns | |||||
| ROE | 8.3% | 8.3% | -59.8% | -0.7% | -3.1% |
| Valuation | |||||
| P/E | 182.61 | 182.61 | — | — | — |
| EV/EBITDA | 13.21 | 13.21 | — | 25.22 | 81.97 |
| P/B | 16.40 | 16.40 | 5.71 | 2.08 | 2.53 |
| Growth & Yield | |||||
| Revenue Growth | 279.3% | 279.3% | -52.2% | -17.0% | — |
| EPS Growth | 108.6% | 108.6% | -4779.5% | 77.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
159.5%
EPS terminal req.
$7.13
Spread vs growth
-50.9%
5Y implied EPS CAGR
84.1%
EPS terminal req.
$8.63
Spread vs growth
24.5%
10Y implied EPS CAGR
42.3%
EPS terminal req.
$13.89
Spread vs growth
66.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+61.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-4.76 → 0.41
Residual
+61.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.